Teva Pharmaceutical Industries Limited (LON: 0LER)

Market Cap	20.28B
Revenue (ttm)	12.51B
Net Income (ttm)	-715.51M
Shares Out	n/a
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,067
Average Volume	10,645
Open	22.15
Previous Close	21.96
Day's Range	21.43 - 22.18
52-Week Range	8.26 - 18.11
Beta	n/a
RSI	60.84
Earnings Date	Jan 28, 2025

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. ...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 36,472
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0LER

Financial Performance

In 2023, Teva Pharmaceutical Industries's revenue was $15.85 billion, an increase of 6.17% compared to the previous year's $14.93 billion. Losses were -$559.00 million, -77.15% less than in 2022.

Financial numbers in USD